Find insight on Fresnillo, the copper market, Australian mining, and more in the latest Market Talks covering Basic Materials ...

High-rolling investors have positioned themselves bullish on Biogen BIIB, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of ...

Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...

Canaccord analyst Kingsley Crane raised the firm’s price target on CrowdStrike (CRWD) to $420 from $370 and keeps a Buy rating on the shares.

Canaccord raised the firm’s price target on Okta (OKTA) to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported ...

The looming end to Australia’s $40bn hybrid securities market represents a big opportunity for stockbroking veteran Geoff ...

Morgan Stanley reaffirmed Tesla as its top pick, maintaining a $430 price target despite mixed analyst ratings. Some firms, ...

TTEC (NASDAQ:TTEC – Free Report) had its target price reduced by Canaccord Genuity Group from $4.50 to $3.50 in a research ...

Canaccord Genuity Group reaffirmed their buy rating on shares of Science Group (LON:SAG – Free Report) in a research note published on Monday,Digital Look reports. Canaccord Genuity Group currently ...

Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, March 03, 2025 (GLOBE NEWSWIRE) ...